Targanta Therapeutics Corp.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Delisting / listing-standard notice · Change in control · Director / officer change · Amended charter or bylawsMar 2, 2009
- Entered a material agreementJan 14, 2009
- Costs from exit or disposal · Director / officer changeDec 19, 2008
- Other material eventDec 9, 2008
- Other material eventNov 20, 2008
- Results of operationsNov 12, 2008
- Other material eventOct 22, 2008
- Other material eventOct 15, 2008
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G HOLDINGS REPORTMar 30, 2009
- 15-12BMar 11, 2009
- EFFECTMar 10, 2009
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Mar 9, 2009
- POS AMPOST-EFFECTIVE AMENDMENT TO FORM S-3Mar 9, 2009
- 8-K/AAMENDMENT TO FORM 8-KMar 6, 2009
- 8-KFORM 8-KMar 2, 2009
- 4MAIN DOCUMENT DESCRIPTIONFeb 27, 2009
- 4MAIN DOCUMENT DESCRIPTIONFeb 27, 2009
- 4MAIN DOCUMENT DESCRIPTIONFeb 27, 2009
- 4MAIN DOCUMENT DESCRIPTIONFeb 27, 2009
- 4Feb 27, 2009
- 25-NSEFeb 26, 2009
- SC 14D9/AAMENDMENT NO. 5 TO SCHEDULE 14D-9Feb 25, 2009
- SC 13D/AAMENDMENT NO. 5 TO SCHEDULE TOFeb 25, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.